Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses
Research and development	$ 114,935	$ 6,721
Sales and marketing	6,186	1,682
General and administrative	27,880	10,993
Total operating expenses	149,001	19,396
Loss from operations	(149,001)	(19,396)
Change in fair value measurements	1,186	(26,917)
Interest expense	(3,746)	(19,174)
Related party interest expense	(622)	(9,752)
Other expense, net	(915)	(283)
Loss before income taxes	(153,098)	(75,522)
Income tax provision	0	(3)
Net loss	(153,098)	(75,525)
Total comprehensive loss:
Net loss	(153,098)	(75,525)
Change in foreign currency translation adjustment	(564)	508
Total comprehensive loss	$ (153,662)	$ (75,017)
Class A Common Stock
Per share information:
Net loss per Common Stock – basic (in dollars per share)	$ (0.48)	$ (0.48)
Net loss per Common Stock – diluted (in dollars per share)	$ (0.48)	$ (0.48)
Weighted average Common shares outstanding – basic (in shares)	322,211,392	158,088,382
Weighted average Common shares outstanding – diluted (in shares)	322,211,392	158,088,382
Class B Common Stock
Per share information:
Net loss per Common Stock – basic (in dollars per share)	$ (0.48)	$ (0.48)
Net loss per Common Stock – diluted (in dollars per share)	$ (0.48)	$ (0.48)
Weighted average Common shares outstanding – basic (in shares)	322,211,392	158,088,382
Weighted average Common shares outstanding – diluted (in shares)	322,211,392	158,088,382